Cellectar Biosciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLRB and other ETFs, options, and stocks.About CLRB
Cellectar Biosciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma, CLR 125, which intends to treat micro metastatic disease, CLR 124, which could detect tumors and metastases in a broad range of cancers, and CLR 1502, a cancer-targeting near-infrared-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination.
CLRB Key Statistics
Stock Snapshot
As of today, Cellectar Biosciences(CLRB) shares are valued at $2.52. The company's market cap stands at 20.14M, with a P/E ratio of -0.34.
During the trading session on 2026-07-21, Cellectar Biosciences(CLRB) shares reached a daily high of $2.55 and a low of $2.48. At a current price of $2.52, the stock is +1.7% higher than the low and still -1.2% under the high.
Trading activity shows a volume of 13.81K, compared to an average daily volume of 121.65K.
Over the past 52 weeks, Cellectar Biosciences(CLRB) stock has traded between a high of $6.52 and a low of $2.20.
Over the past 52 weeks, Cellectar Biosciences(CLRB) stock has traded between a high of $6.52 and a low of $2.20.
CLRB News
Cellectar Biosciences (CLRB) announced the publication of results from a Phase 1 dose-escalation study evaluating iopofosine I 131 in combination with low-dose...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.